PMID: 1203873Dec 1, 1975Paper

Incidence, mortality or prevalence as indicators of the cancer problem

Cancer
M HakamaE Saxen

Abstract

The magnitude of the cancer problem, as conveyed by the incidence, mortality and prevalence figures, was studied by analysis of the material of the Finnish Cancer Registry from 1953-1970. The prevalence was defined as the number of persons who had cancer, or had ever had cancer, and were living on December 31, 1970. The incidence and mortality of cancer in males exceeded those in respect of females, whereas the prevalence with females was clearly higher than that with males. According to all 3 indices, the commonest site of cancer was in the lungs in males. In females, cancer of the breast was the commonest malignant neoplasm measured by incidence and prevalence, where as in mortality statistics it was second to cancer of the stomach. Cancers with poor prognosis such as cancer of the lung, stomach, pancreas and esophagus, and leukemia, exhibited relatively low prevalence figures, whereas cancers with good prognosis, such as cancer of the breast, uterus, larynx and lip, showed relatively large numbers of prevalent cases. In females, cancer of the genitals, including the breasts, constituted nearly as may prevalent cases as did the total figure in males. As the 3 cancer indices measure different things, the nature of the index us...Continue Reading

References

Jan 1, 1974·Journal of the National Cancer Institute·J L Murray, L M Axtell
Jan 1, 1959·Schweizerische Zeitschrift für Pathologie und Bakteriologie. Revue suisse de pathologie et de bactériologie·M SEGIM KURIHARA

❮ Previous
Next ❯

Citations

Jul 19, 2002·Cancer·Andrea MicheliLynn Ries
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
Jan 1, 1983·Journal of Cancer Research and Clinical Oncology·K Kayser, H U Burkhardt
May 9, 2008·International Journal of Clinical Oncology·Donald Maxwell Parkin
Apr 25, 2006·Cancer Causes & Control : CCC·Rahul RoychoudhuriHenrik Møller
May 24, 1978·Biochimica Et Biophysica Acta·J V KilmartinJ M Baldwin
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A MicheliUNKNOWN EUROPREVAL Working Group
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R CapocacciaUNKNOWN EUROPREVAL Working Group
Apr 15, 1976·International Journal of Cancer. Journal International Du Cancer·T Hakulinen, L Teppo
Jan 1, 1982·International Archives of Occupational and Environmental Health·I KilpikariM Hakama
Sep 1, 1983·Diseases of the Colon and Rectum·M J Turunen, P Peltokallio
Oct 1, 1976·The American Journal of Digestive Diseases·A R Walker, D P Burkitt
Dec 8, 2004·Social Psychiatry and Psychiatric Epidemiology·Heli Koivumaa-HonkanenMarkku Koskenvuo
Apr 1, 1981·Medical Informatics = Médecine Et Informatique·K Kayser, H U Burkhardt
Jan 1, 1989·Acta Oncologica·H O AdamiG Eklund
Sep 14, 2011·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Te-Fu ChanChun-Yuh Yang
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P GhadirianC Perret
Jan 20, 2005·BMC Psychiatry·Heli Koivumaa-HonkanenMarkku Koskenvuo
Mar 1, 1980·Journal of Epidemiology and Community Health·M Hakama, R West
Dec 24, 2005·American Journal of Epidemiology·Marianne HinkulaEero Pukkala
Jan 5, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·H Koivumaa-HonkanenM Koskenvuo
Jan 1, 1986·Community Health Studies·A BonettT MacHarper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.